jondoeuk
13 minutes ago
For both (mono and combo), patients receive a single dose of FT825. Based on the safety, tolerability, and radiographically confirmed clinical benefit to treatment (I assume SD or PR, but not CR), they may be considered for an additional treatment (retreatment). As for the combo, I don't know how ma
dinogreeves
16 minutes ago
This is going to run big, kind of resembles AM*C run. Whoever is in this for a trade to make ends meet and pay bills, will be sorry. I already made my rounds trading stocks, DRU*G, RDA*R, AZR*H, and JDZ*G and a few between don't even remember, needless to say, within the last 2 months I am up 2000